EUR 7.64
(9.46%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 3.51 Million EUR | -5.37% |
2022 | 8.68 Million EUR | 13.14% |
2021 | 7.67 Million EUR | 18.45% |
2020 | 6.47 Million EUR | -26.56% |
2019 | 8.81 Million EUR | 10.89% |
2018 | 7.95 Million EUR | 28.15% |
2017 | 6.2 Million EUR | -15.71% |
2016 | 7.36 Million EUR | -12.58% |
2015 | 8.42 Million EUR | 15.28% |
2014 | 7.3 Million EUR | 28.66% |
2013 | 5.67 Million EUR | 12.27% |
2012 | 5.05 Million EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 1.56 Million EUR | 0.0% |
2023 FY | 8.21 Million EUR | -5.37% |
2023 Q2 | 1.47 Million EUR | -27.22% |
2023 Q3 | 2.08 Million EUR | 41.73% |
2023 Q1 | 2.02 Million EUR | 28.84% |
2023 Q4 | 1.6 Million EUR | -22.97% |
2022 Q3 | 2.1 Million EUR | 17.77% |
2022 Q4 | 1.57 Million EUR | -25.24% |
2022 Q2 | 1.78 Million EUR | -20.69% |
2022 FY | 8.68 Million EUR | 13.14% |
2022 Q1 | 2.24 Million EUR | 47.18% |
2021 Q2 | 1.53 Million EUR | -17.71% |
2021 FY | 7.67 Million EUR | 18.45% |
2021 Q4 | 1.52 Million EUR | -26.04% |
2021 Q3 | 2.06 Million EUR | 34.31% |
2021 Q1 | 1.86 Million EUR | 77.38% |
2020 Q3 | 1.66 Million EUR | 25.59% |
2020 Q2 | 1.32 Million EUR | -15.9% |
2020 Q1 | 1.57 Million EUR | -5.22% |
2020 FY | 6.47 Million EUR | -26.56% |
2020 Q4 | 1.05 Million EUR | -36.64% |
2019 Q3 | 2.3 Million EUR | 17.46% |
2019 FY | 8.81 Million EUR | 10.89% |
2019 Q1 | 2.12 Million EUR | -12.67% |
2019 Q2 | 1.96 Million EUR | -7.75% |
2019 Q4 | 1.66 Million EUR | -27.88% |
2018 Q1 | 1.73 Million EUR | 2.74% |
2018 FY | 7.95 Million EUR | 28.15% |
2018 Q4 | 2.43 Million EUR | 0.0% |
2018 Q2 | 1.73 Million EUR | 0.0% |
2018 Q3 | 2.43 Million EUR | 40.37% |
2017 Q3 | 1.68 Million EUR | -22.33% |
2017 FY | 6.2 Million EUR | -15.71% |
2017 Q2 | 2.17 Million EUR | 0.0% |
2017 Q1 | 2.17 Million EUR | 19.3% |
2017 Q4 | 1.68 Million EUR | 0.0% |
2016 Q2 | 2.45 Million EUR | 0.0% |
2016 Q4 | 1.82 Million EUR | 0.0% |
2016 FY | 7.36 Million EUR | -12.58% |
2016 Q3 | 1.82 Million EUR | -25.73% |
2016 Q1 | 2.45 Million EUR | -30.61% |
2015 Q4 | 3.53 Million EUR | 0.0% |
2015 Q3 | 3.53 Million EUR | 38.01% |
2015 FY | 8.42 Million EUR | 15.28% |
2015 Q1 | 2.56 Million EUR | -11.06% |
2015 Q2 | 2.56 Million EUR | 0.0% |
2014 Q3 | 2.88 Million EUR | 67.49% |
2014 FY | 7.3 Million EUR | 28.66% |
2014 Q4 | 2.88 Million EUR | 0.0% |
2014 Q2 | 1.71 Million EUR | 0.0% |
2014 Q1 | 1.71 Million EUR | 15.32% |
2013 Q3 | 1.49 Million EUR | 8.03% |
2013 Q4 | 1.49 Million EUR | 0.0% |
2013 Q2 | 1.38 Million EUR | 0.0% |
2013 FY | 5.67 Million EUR | 12.27% |
2013 Q1 | 1.38 Million EUR | 207.46% |
2012 FY | 5.05 Million EUR | 0.0% |
2012 Q1 | -1.28 Million EUR | 0.0% |
2012 Q2 | -1.28 Million EUR | 0.0% |
2012 Q3 | -1.28 Million EUR | 0.0% |
2012 Q4 | -1.28 Million EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
BBS-Bioactive Bone Substitutes Oyj | 3.36 Million EUR | -4.553% |
Modulight Oyj | 17.11 Million EUR | 79.456% |
Revenio Group Oyj | 18.8 Million EUR | 81.297% |